Generic placeholder image

Current Diabetes Reviews

Author(s): Asha Thomas*, Nilam Bankar, Dheeraj Nagore, Lata Kothapalli and Sohan Chitlange

DOI: 10.2174/1573399817666210322151700

DownloadDownload PDF Flyer Cite As
Herbal Oils for Treatment of Chronic and Diabetic Wounds: A Systematic Review

Article ID: e220321192406 Pages: 11

  • * (Excluding Mailing and Handling)

Explore Articles
About Journal
For Authors
For Editors
For Reviewers

Abstract

Background: In the present scenario, diabetes is a growing health challenge, and its occurrence is growing across the globe. Diabetes, with its complications like diabetic wounds, vasculopathy, neuropathy, wound infections, and oxidative stress, is a serious cause of mortality worldwide.

Introduction: Among the various complications, treatment of diabetic foot and ulcers is one of the major concerns in patients who are suffering from diabetes. The causative factors for this condition include increased oxidative stress, high blood glucose levels, vascular insufficiency, and microbial infections, and many a time, if left untreated, it may even lead to amputations of the lower extremities. The present therapy for the treatment of diabetic wounds mainly involves the use of synthetic moieties and other biotechnology-derived biomolecules, including growth factors. Few plant products are also useful in the treatment of wounds.

Methods: Essential oils derived from various herbs are reported to possess significant wound healing potential and promote blood clotting, help to fight infections, and accelerate the wound healing process. Hence, the present review is a systematic analysis of all the available data on the use of the natural oils with their biological source, active phytochemical constituents present, and the probable mechanism of action for the treatment of chronic and diabetic wounds in suitable animal models. A methodical collection of data was performed, and information was searched up to April 2020 in entirety. Key phrases used for the data search include the pathophysiology of wounds, diabetic foot wound and its complications, natural oils for chronic and diabetic wound treatment.

Results: This review summarizes the natural oils which are reported in the literature to be beneficial in the treatment of chronic wounds, while some oils have been specifically also studied against wounds in diabetic rats. Essential oils are said to interact with the body pharmacologically, physiologically and psychologically and help in rapid wound healing. However, the majority of the literature studies have demonstrated wound healing activity only in animal models (preclinical data), and further clinical studies are necessary.

Conclusion: This review provides a platform for further studies on the effective utilization of natural oils in the treatment of chronic and diabetic wounds, especially if oils are to receive credibility in the management of chronic wounds.

Keywords: Chronic wounds, diabetes, diabetic wounds, herbal oils, natural oils, wound management.

[1]
Sudharsanan N, Ali MK, Mehta NK, Narayan KM. Population aging, macroeconomic changes, and global diabetes prevalence, 1990-2008. Popul Health Metr 2015; 13(1): 33.
[http://dx.doi.org/10.1186/s12963-015-0065-x] [PMID: 26640415]
[2]
King H, Rewers M. WHO Ad Hoc Diabetes Reporting Group. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 1993; 16(1): 157-77.
[http://dx.doi.org/10.2337/diacare.16.1.157] [PMID: 8123057]
[3]
King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care 1998; 21(9): 1414-31.
[http://dx.doi.org/10.2337/diacare.21.9.1414] [PMID: 9727886]
[4]
National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. diabetes 1979 Dec; 28(12)1: 1039-57.
[5]
Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res 2007; 125(3): 217-30.
[PMID: 17496352]
[6]
Jeffcoate WJ, Price P, Harding KG. International working group on wound healing and treatments for people with diabetic foot ulcers. Wound healing and treatments for people with diabetic foot ulcers. Diabetes Metab Res Rev 2004; 20(Suppl. 1): S78-89.
[http://dx.doi.org/10.1002/dmrr.476] [PMID: 15150819]
[7]
Karri VV, Kuppusamy G, Talluri SV, Yamjala K, Mannemala SS, Malayandi R. Current and emerging therapies in the management of diabetic foot ulcers. Cur Med Res Opin 2016; 332(3): 519-42.
[http://dx.doi.org/10.1185/03007995.2015.1128888]
[8]
Hile C, Veves A. Diabetic neuropathy and microcirculation. Curr Diabetes Rep 2003 Nov; 13(6): 446-51.
[http://dx.doi.org/10.1007/s11892-003-0006-0]
[9]
Flynn MD, Tooke JE. Aetiology of diabetic foot ulceration: A role for the microcirculation? Diabet Med 1992; 9(4): 320-9.
[http://dx.doi.org/10.1111/j.1464-5491.1992.tb01790.x] [PMID: 1600701]
[10]
Ackermann PW, Hart DA. Influence of comorbidities: Neuropathy, vasculopathy, and diabetes on healing response quality. Adv Wound Care 2013; 12(8): 410-21.
[http://dx.doi.org/10.1089/wound.2012.0437]
[11]
Loots MA, Lamme EN, Zeegelaar J, Mekkes JR, Bos JD, Middelkoop E. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol 1998; 1111(5): 850-7.
[http://dx.doi.org/10.1046/j.1523-1747.1998.00381.x]
[12]
Ctercteko GC, Dhanendran M, Hutton WC, Le Quesne LP. Vertical forces acting on the feet of diabetic patients with neuropathic ulceration. Br J Surg 1981; 68(9): 608-14.
[http://dx.doi.org/10.1002/bjs.1800680904] [PMID: 7272685]
[13]
Laing P. The development and complications of diabetic foot ulcers. Am J Surg 1998; 176(2A)(Suppl.): 11S-9S.
[http://dx.doi.org/10.1016/S0002-9610(98)00182-2] [PMID: 9777968]
[14]
Sugarman JR, Reiber GE, Baumgardner G, Prela CM, Lowery J. Use of the therapeutic footwear benefit among diabetic medicare beneficiaries in three states, 1995. Diabetes Care 1998; 21(5): 777-81.
[http://dx.doi.org/10.2337/diacare.21.5.777] [PMID: 9589239]
[15]
Gonzalez ER, Oley MA. The management of lower-extremity diabetic ulcers. Manag Care Interface 2000; 13(11): 80-7.
[PMID: 11188237]
[16]
Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care 1990; 13(5): 513-21.
[http://dx.doi.org/10.2337/diacare.13.5.513] [PMID: 2351029]
[17]
American Diabetes Association. Consensus Development Conference on Diabetic Foot Wound Care. Diabetes Care 1999; 22: 1354.
[18]
Armstrong DG, Liswood PJ, Todd WF. Prevalence of mixed infections in the diabetic pedal wound. A retrospective review of 112 infections. J Am Podiatr Med Asoc 1995; 85: 533-7.
[19]
Gerding DN. Foot infections in diabetic patients: The role of anaerobes. Clin Infect Dis 1995; 20(Suppl. 2): S283-8.
[http://dx.doi.org/10.1093/clinids/20.Supplement_2.S283] [PMID: 7548576]
[20]
Serra R, Grande R, Butrico L, et al. Chronic wound infections: The role of Pseudomonas aeruginosa and Staphylococcus aureus. Expert Rev Anti Infect Ther 2015; 13(5): 605-13.
[http://dx.doi.org/10.1586/14787210.2015.1023291] [PMID: 25746414]
[21]
Dowd SE, Delton Hanson J, Rees E, et al. Survey of fungi and yeast in polymicrobial infections in chronic wounds. J Wound Care 2011; 20(1): 40-7.
[http://dx.doi.org/10.12968/jowc.2011.20.1.40] [PMID: 21278640]
[22]
Vermitsky JP, Edlind TD. Azole resistance in Candida glabrata: Coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor. Antimicrob Agents Chemother 2004; 48(10): 3773-81.
[http://dx.doi.org/10.1128/AAC.48.10.3773-3781.2004] [PMID: 15388433]
[23]
Gary Sibbald R, Woo KY. The biology of chronic foot ulcers in persons with diabetes. Diabetes Metab Res Rev 2008; 24(S1)(Suppl. 1): S25-30.
[http://dx.doi.org/10.1002/dmrr.847] [PMID: 18442179]
[24]
Tavafi M. Diabetic nephropathy and antioxidants. J Nephropathol 2013; 2(1): 20-7.
[http://dx.doi.org/10.5812/nephropathol.9093] [PMID: 24475422]
[25]
King GL, Loeken MR. Hyperglycemia-induced oxidative stress in diabetic complications. Histochem Cell Biol 2004; 122(4): 333-8.
[http://dx.doi.org/10.1007/s00418-004-0678-9] [PMID: 15257460]
[26]
Mshelia DS. Role of free radicals in pathogenesis of diabetes nephropathy. Ann Afr Med 2004; 3(2): 55-62.
[27]
Loft S, Vistisen K, Ewertz M, Tjønneland A, Overvad K, Poulsen HE. Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: Influence of smoking, gender and body mass index. Carcinogenesis 1992; 13(12): 2241-7.
[http://dx.doi.org/10.1093/carcin/13.12.2241] [PMID: 1473230]
[28]
Young M J, Cavanagh P R, Thomas G, Johnson M M, Murray H, Boulton A J. The effect of callus removal on dynamic plantar foot pressures in diabetic patients. Diabetic Medicine 1992 Jan; 29(1): 55-7.
[http://dx.doi.org/10.1111/j.1464-5491.1992.tb01714.x]
[29]
Barrett JP, Mooney V. Neuropathy and diabetic pressure lesions. Orthop Clin North Am 1973; 4(1): 43-7.
[http://dx.doi.org/10.1016/S0030-5898(20)30503-4] [PMID: 4682373]
[30]
Van Deursen R. Mechanical loading and off-loading of the plantar surface of the diabetic foot. Clin Infect Dis 2004; 139(Supplement_2): S87-91.
[http://dx.doi.org/10.1086/383268]
[31]
Aumiller WD, Dollahite HA. Pathogenesis and management of diabetic foot ulcers. JAAPA 2015; 28(5): 28-34.
[http://dx.doi.org/10.1097/01.JAA.0000464276.44117.b1] [PMID: 25853673]
[32]
Clayton W, Elasy TA. A review of the pathophysiology, classification, and treatment of foot ulcers in diabetic patients. Clin Diabetes 2009; 27(2): 52-8.
[http://dx.doi.org/10.2337/diaclin.27.2.52]
[33]
Patel S, Srivastava S, Singh MR, Singh D. Mechanistic insight into diabetic wounds: Pathogenesis, molecular targets and treatment strategies to pace wound healing. Biomed Pharmacother 2019; 112: 108615.
[http://dx.doi.org/10.1016/j.biopha.2019.108615] [PMID: 30784919]
[34]
Arya AK, Garg S, Kumar S, Meena LP, Tripathi K. Estimation of lymphocyte apoptosis in patients with chronic non-he aling diabetic foot ulcer. Int J Med Sci Public Health 2013; 2(4): 766-8.
[http://dx.doi.org/10.5455/ijmsph.2013.100620132]
[35]
Grant M, Jerdan J, Merimee TJ. Insulin-like growth factor-I modulates endothelial cell chemotaxis. J Clin Endocrinol Metab 1987; 65(2): 370-1.
[http://dx.doi.org/10.1210/jcem-65-2-370] [PMID: 3597713]
[36]
Blakytny R, Jude E. The molecular biology of chronic wounds and delayed healing in diabetes. Diabet Med 2006; 23(6): 594-608.
[http://dx.doi.org/10.1111/j.1464-5491.2006.01773.x] [PMID: 16759300]
[37]
Falanga V. Wound healing and its impairment in the diabetic foot. Lancet 2005; 366(9498): 1736-43.
[http://dx.doi.org/10.1016/S0140-6736(05)67700-8] [PMID: 16291068]
[38]
Lavery LA, Armstrong DG, Harkless LB. Classification of diabetic foot wounds. J Foot Ankle Surg 1996; 135(6): 528-31.
[http://dx.doi.org/10.1016/S1067-2516(96)80125-6]
[39]
Senior C. Assessment of infection in diabetic foot ulcers. J Wound Care 2000; 9(7): 313-7.
[http://dx.doi.org/10.12968/jowc.2000.9.7.25999] [PMID: 11933415]
[40]
Galiano RD, Tepper OM, Pelo CR, et al. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol 2004; 164(6): 1935-47.
[http://dx.doi.org/10.1016/S0002-9440(10)63754-6] [PMID: 15161630]
[41]
Li H, Fu X, Zhang L, Huang Q, Wu Z, Sun T. Research of PDGF-BB gel on the wound healing of diabetic rats and its pharmacodynamics. J Surg Res 2008; 145(1): 41-8.
[http://dx.doi.org/10.1016/j.jss.2007.02.044] [PMID: 18082770]
[42]
Gallagher KA, Liu ZJ, Xiao M, et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest 2007; 117(5): 1249-59.
[http://dx.doi.org/10.1172/JCI29710] [PMID: 17476357]
[43]
Keswani SG, Katz AB, Lim FY, et al. Adenoviral mediated gene transfer of PDGF-B enhances wound healing in type I and type II diabetic wounds. Wound Repair Regen 2004; 12(5): 497-504.
[http://dx.doi.org/10.1111/j.1067-1927.2004.12501.x] [PMID: 15453831]
[44]
Badillo AT, Chung S, Zhang L, Zoltick P, Liechty KW. Lentiviral gene transfer of SDF-1alpha to wounds improves diabetic wound healing. J Surg Res 2007; 143(1): 35-42.
[http://dx.doi.org/10.1016/j.jss.2007.03.051] [PMID: 17950070]
[45]
Gibran NS, Jang YC, Isik FF, et al. Diminished neuropeptide levels contribute to the impaired cutaneous healing response associated with diabetes mellitus. J Surg Res 2002; 108(1): 122-8.
[http://dx.doi.org/10.1006/jsre.2002.6525] [PMID: 12443724]
[46]
Hamed S, Ullmann Y, Masoud M, Hellou E, Khamaysi Z, Teot L. Topical erythropoietin promotes wound repair in diabetic rats. J Invest Dermatol 2010; 130(1): 287-94.
[http://dx.doi.org/10.1038/jid.2009.219] [PMID: 19626038]
[47]
Apikoglu-Rabus S, Izzettin FV, Turan P, Ercan F. Effect of topical insulin on cutaneous wound healing in rats with or without acute diabetes. Clin Exp Dermatol 2010; 35(2): 180-5.
[http://dx.doi.org/10.1111/j.1365-2230.2009.03419.x] [PMID: 19594766]
[48]
Fujita N, Sakaguchi I, Kobayashi H, et al. An extract of the root of Lithospermun erythrorhison accelerates wound healing in diabetic mice. Biol Pharm Bull 2003; 26(3): 329-35.
[http://dx.doi.org/10.1248/bpb.26.329] [PMID: 12612442]
[49]
Lau TW, Lam FF, Lau KM, et al. Pharmacological investigation on the wound healing effects of Radix Rehmanniae in an animal model of diabetic foot ulcer. J Ethnopharmacol 2009; 123(1): 155-62.
[http://dx.doi.org/10.1016/j.jep.2009.02.010] [PMID: 19429355]
[50]
Dwivedi VK, Chaudhary M. Comparative wound healing efficacy of ampucare and becaplermin in diabetic rat. Afr J Pharm Pharmacol 2012; 6: 883-92.
[51]
Rex JRS, Nadar M, Selvakumar PM. Phytochemicals as a potential source for anti-microbial, anti-oxidant and wound healing - a review. MOJ Biorg Org Chem 2018; 2(2): 61-70.
[52]
Oh YS. Plant-derived compounds targeting pancreatic beta cells for the treatment of diabetes. Evid Based Complement Alternat Med 2015; 2015: 629863.
[http://dx.doi.org/10.1155/2015/629863] [PMID: 26587047]
[53]
Thangapazham RL, Sharad S, Maheshwari RK. Phytochemicals in wound healing. Adv Wound Care (New Rochelle) 2016; 5(5): 230-41.
[http://dx.doi.org/10.1089/wound.2013.0505] [PMID: 27134766]
[54]
Pereira RF, Bártolo PJ. Traditional therapies for skin wound healing. Adv Wound Care (New Rochelle) 2016; 5(5): 208-29.
[http://dx.doi.org/10.1089/wound.2013.0506] [PMID: 27134765]
[55]
Ambika AP, Nair SN. Wound healing activity of plants from the convolvulaceae family. Adv Wound Care (New Rochelle) 2019; 8(1): 28-37.
[http://dx.doi.org/10.1089/wound.2017.0781] [PMID: 30705787]
[56]
Shah A, Amini-Nik S. The role of phytochemicals in the inflammatory phase of wound healing. Int J Mol Sci 2017; 18(5): 1068.
[http://dx.doi.org/10.3390/ijms18051068] [PMID: 28509885]
[57]
Gaspar-Pintiliescu A, Stanciuc AM, Craciunescu O. Natural composite dressings based on collagen, gelatin and plant bioactive compounds for wound healing: A review. Int J Biol Macromol 2019; 138: 854-65.
[http://dx.doi.org/10.1016/j.ijbiomac.2019.07.155] [PMID: 31351963]
[58]
Patil S, Goswami A, Kalia K, Kate A. Plant-derived bioactive peptides: A treatment to cure diabetes. Int J Pept Res Ther 2019; 26.
[http://dx.doi.org/10.1007/s10989-019-09899-z] [PMID: 32435169]
[59]
Braca A, Siciliano T, D’Arrigo M, Germanò MP. Chemical composition and antimicrobial activity of Momordica charantia seed essential oil. Fitoterapia 2008; 79(2): 123-5.
[http://dx.doi.org/10.1016/j.fitote.2007.11.002] [PMID: 18164872]
[60]
Basch E, Gabardi S, Ulbricht C. Bitter melon (Momordica charantia): A review of efficacy and safety. Am J Health Syst Pharm 2003; 60(4): 356-9.
[http://dx.doi.org/10.1093/ajhp/60.4.356] [PMID: 12625217]
[61]
Ahmad Z, Zamhuri KF, Yaacob A, et al. In vitro anti-diabetic activities and chemical analysis of polypeptide-k and oil isolated from seeds of Momordica charantia (bitter gourd). Molecules 2012; 17(8): 9631-40.
[http://dx.doi.org/10.3390/molecules17089631] [PMID: 22885359]
[62]
İlhan M, Bolat IE, Süntar İ, Köklü DAU. Çankal, H. Keleş, E. K. Akkol, Topical application of olive oil macerate of Momordicacharantia L. promotes healing of excisional and incisional wounds in rat buccal mucosa. Arch Oral Biol 2015; 60(12): 1708-13.
[http://dx.doi.org/10.1016/j.archoralbio.2015.09.006] [PMID: 26431827]
[63]
Pereira Dos Santos E, Nicácio PHM, Coêlho Barbosa F, et al. Chitosan/essential oils formulations for potential use as wound dressing: Physical and antimicrobial properties. Materials (Basel) 2019; 12(14): 2223.
[http://dx.doi.org/10.3390/ma12142223] [PMID: 31295876]
[64]
Barboza JN, da Silva Maia BezerraFilho, Silva R O, et al. An overview on the anti-inflammatory potential and antioxidant profile of eugenol. Oxid Med Cell Longev 2018; 23-6.
[65]
Wang J, Liu YT, Xiao L, Zhu L, Wang Q, Yan T. Anti-inflammatory effects of apigenin in lipopolysaccharide-induced inflammatory in acute lung injury by suppressing COX-2 and NF-kB pathway. Inflammation 2014; 37(6): 2085-90.
[http://dx.doi.org/10.1007/s10753-014-9942-x]
[66]
Hussain T, Tan B, Yin Y, Blachier F, Tossou MCB, Rahu N. Oxidative stress and inflammation: What polyphenols can do for us? Oxid Med Cell Longev 2016; 2016: 7432797.
[67]
Briozzo J, Núñez L, Chirife J, Herszage L, D’Aquino M. Antimicrobial activity of clove oil dispersed in a concentrated sugar solution. J Appl Bacteriol 1989; 66(1): 69-75.
[http://dx.doi.org/10.1111/j.1365-2672.1989.tb02456.x] [PMID: 2542213]
[68]
Alam P, Ansari MJ, Anwer MK, Raish M, Kamal YK, Shakeel F. Wound healing effects of nanoemulsion containing clove essential oil. Artif Cells Nanomed Biotechnol 2017; 45(3): 591-7.
[http://dx.doi.org/10.3109/21691401.2016.1163716] [PMID: 28211300]
[69]
Manzuoerh R, Farahpour MR, Oryan A, Sonboli A. Effectiveness of topical administration of Anethum graveolens essential oil on MRSA-infected wounds. Biomed Pharmacother 2019; 109(109): 1650-8.
[http://dx.doi.org/10.1016/j.biopha.2018.10.117] [PMID: 30551419]
[70]
Hamza L F. Anethumgraveolens: Physicochemical properties, medicinal uses, antimicrobial effects, antioxidant effect, anti-inflammatory and analgesic effects: A review. world 2017; 5: 7.
[71]
Evandri MG, Battinelli L, Daniele C, Mastrangelo S, Bolle P, Mazzanti G. The antimutagenic activity of Lavandula angustifolia (lavender) essential oil in the bacterial reverse mutation assay. Food Chem Toxicol 2005; 43(9): 1381-7.
[http://dx.doi.org/10.1016/j.fct.2005.03.013] [PMID: 15907354]
[72]
Mayaud L, Carricajo A, Zhiri A, Aubert G. Comparison of bacteriostatic and bactericidal activity of 13 essential oils against strains with varying sensitivity to antibiotics. Lett Appl Microbiol 2008; 47(3): 167-73.
[http://dx.doi.org/10.1111/j.1472-765X.2008.02406.x] [PMID: 19552780]
[73]
Vakilian K, Atarha M, Bekhradi R, Chaman R. Healing advantages of lavender essential oil during episiotomy recovery: A clinical trial. Complement Ther Clin Pract 2011; 17(1): 50-3.
[http://dx.doi.org/10.1016/j.ctcp.2010.05.006] [PMID: 21168115]
[74]
Hui L, He L, Huan L, Li XL, Zhou AG. Chemical composition of lavender essential oil and its antioxidant activity and inhibition against rhinitis related bacteria. Afr J Microbiol Res 2010; 4(4): 309-13.
[75]
Lusby PE, Coombes AL, Wilkinson JM. A comparison of wound healing following treatment with Lavandula x allardii honey or essential oil. Phytother Res 2006; 20(9): 755-7.
[http://dx.doi.org/10.1002/ptr.1949] [PMID: 16807876]
[76]
Crisosto CH, Nanos G. Post-Harvest Biology and Technology of Tropical and Subtropical Fruits Mangosteen to White Sapote 2011.
[77]
Visioli F, Bellomo G, Galli C. Free radical-scavenging properties of olive oil polyphenols. Biochem Biophys Res Commun 1998; 247(1): 60-4.
[http://dx.doi.org/10.1006/bbrc.1998.8735] [PMID: 9636654]
[78]
Panahi Y, Izadi M, Sayyadi N, et al. Comparative trial of Aloe vera/olive oil combination cream versus phenytoin cream in the treatment of chronic wounds J Wound Care 2015; 24: 459-60.: 462-0.
[79]
Donato-Trancoso A, Monte-Alto-Costa A, Romana-Souza B. Olive oil-induced reduction of oxidative damage and inflammation promotes wound healing of pressure ulcers in mice. J Dermatol Sci 2016; 83(1): 60-9.
[http://dx.doi.org/10.1016/j.jdermsci.2016.03.012] [PMID: 27091748]
[80]
Lima EBC, Sousa CNS, Meneses LN, et al. Cocos nucifera (L.) (Arecaceae): A phytochemical and pharmacological review. Braz J Med Biol Res 2015; 48(11): 953-64.
[http://dx.doi.org/10.1590/1414-431x20154773] [PMID: 26292222]
[81]
Soliman AM, Lin TS, Ghafar NA, Das S. Virgin coconut oil and diabetic wound healing: Histopathological and biochemical analysis. Eur J Anat 2018; 22(2): 135-44.
[82]
Nevin KG, Rajamohan T. Effect of topical application of virgin coconut oil on skin components and antioxidant status during dermal wound healing in young rats. Skin Pharmacol Physiol 2010; 23(6): 290-7.
[http://dx.doi.org/10.1159/000313516] [PMID: 20523108]
[83]
Coconut, a. w. h. e. o. International Journal of Medicine and Health Profession Research. Methods 1985; 85(23): 12.
[84]
Sa'at A, Rosli R, Syakroni N. Potential hypoglycemic property of Albiziamyriophylla and virgin coconut oil in streptozotocin induced diabetic rats. Int J Pharm Pharm Sci 2013; 5(4): 199-202.
[85]
Garfinkel M, Lee S, Opara EC, Akwari OE. Insulinotropic potency of lauric acid: A metabolic rationale for medium chain fatty acids (MCF) in TPN formulation. J Surg Res 1992; 52(4): 328-33.
[http://dx.doi.org/10.1016/0022-4804(92)90111-C] [PMID: 1593871]
[86]
Kandimalla R, Kalita S, Choudhury B, Dash S, Kalita K, Kotoky J. Kotoky, Chemical composition and anti-candidiasis mediated wound healing property of Cymbopogon nardus essential oil on chronic diabetic wounds. Front Pharmacol 2016; 7: 198.
[http://dx.doi.org/10.3389/fphar.2016.00198] [PMID: 27445828]
[87]
Budzyńska A, Różalska S, Sadowska B, Różalska B. B. RóżalskaCandidaalbicans/Staphylococcus aureus dual-species biofilm as a target for the combination of essential oils and fluconazole or mupirocin. Mycopathologia 2017; 182(11-12): 989-95.
[http://dx.doi.org/10.1007/s11046-017-0192-y] [PMID: 28823093]
[88]
Huang XW, Feng YC, Huang Y, Li HL. Chemical composition, antioxidant and the possible use as skin-care ingredient of clove oil (Syzygium aromaticum (L.) Merr. & Perry) and citronella oil (Cymbopogon goeringii) from China. J Essent Oil Res 2013; 25(4): 315-23.
[http://dx.doi.org/10.1080/10412905.2013.775082]
[89]
Wei LS, Wee W. Chemical composition and antimicrobial activity of Cymbopogon nardus citronella essential oil against systemic bacteria of aquatic animals. Iran J Microbiol 2013; 5(2): 147-52.
[PMID: 23825733]
[90]
Asressu KH, Tesema TK. Chemical and antimicrobial investigations on essential oil of Rosmarinus officinalis leaves grown in Ethiopia and comparison with other countries. J Appl Pharm 2014; 6: 132-42.
[http://dx.doi.org/10.21065/19204159.6.3.112]
[91]
Juhás Š, Bukovská A, Čikoš Š, Czikková S, Fabian D, Koppel J. Anti-inflammatory effects of Rosmarinus officinalis essential oil in mice. Acta Vet Brno 2009; 78(1): 121-7.
[http://dx.doi.org/10.2754/avb200978010121]
[92]
Lo AH, Liang YC, Lin-Shiau SY, Ho CT, Lin JK. Carnosol, an antioxidant in rosemary, suppresses inducible nitric oxide synthase through down-regulating nuclear factor-kappaB in mouse macrophages. Carcinogenesis 2002; 23(6): 983-91.
[http://dx.doi.org/10.1093/carcin/23.6.983] [PMID: 12082020]
[93]
Khezri K, Farahpour MR, Mounesi Rad S. Accelerated infected wound healing by topical application of encapsulated Rosemary essential oil into nanostructured lipid carriers. Artif Cells Nanomed Biotechnol 2019; 47(1): 980-8.
[http://dx.doi.org/10.1080/21691401.2019.1582539] [PMID: 30857435]
[94]
Abu-Al-Basal MA. Healing potential of Rosmarinus officinalis L. on full-thickness excision cutaneous wounds in alloxan-induced- diabetic BALB/c mice. J Ethnopharmacol 2010; 131(2): 443-50.
[http://dx.doi.org/10.1016/j.jep.2010.07.007] [PMID: 20633625]
[95]
Sharopov FS, Zhang H, Setzer WN. Composition of geranium (Pelargonium graveolens) essential oil from Tajikistan. Am J Essent Oils Nat Prod 2014; 2(2): 13-6.
[96]
Baker B P, Grant J A. Active ingredients eligible for minimum risk pesticide use. Overview of the Profiles New York State IPM Program, 2018.
[97]
Mahboubi M, Taghizadeh M, Khamechian T, Tamtaji OR, Mokhtari R, Talaei SA. The wound healing effects of herbal cream containing Oliveria decumbens and Pelargonium graveolens essential oils in diabetic foot ulcer model. World J Plast Surg 2018; 7(1): 45-50.
[PMID: 29651391]
[98]
Sienkiewicz M, Poznańska-Kurowska K, Kaszuba A, Kowalczyk E. The antibacterial activity of geranium oil against Gram-negative bacteria isolated from difficult-to-heal wounds. Burns 2014; 40(5): 1046-51.
[http://dx.doi.org/10.1016/j.burns.2013.11.002] [PMID: 24290961]